Regenxbio RGNX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.56M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 12.42% to 15.42% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +1,326,922 | 5.2% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,290,821 | 4.0% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,279,154 | 11.6% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +415,429 | 3.8% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +341,462 | 2.4% |
| TD Asset Management | Mutual Fund | 2026/Q3 | +230,018 | 0.3% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +225,571 | 0.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +182,163 | 4.8% |
| Acadian Asset Management LLC | Mutual Fund | 2026/Q3 | +138,558 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +477,567 | 1.5% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +1,284,950 | 1.9% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +669,023 | 1.0% |
| BlackRock | Mutual Fund | 2026/Q3 | +614,632 | 9.7% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +426,813 | 1.1% |
| Lazard Asset Management LLC | Mutual Fund | 2026/Q3 | +370,375 | 0.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 31 Oct 2026 | Stephen Pakola | Chief Medical Officer | Other Acquisition | +34,722 | – | 187,461 |
| 31 Oct 2026 | Patrick Christmas | Executive VP and Chief Strategy & Legal Officer | Other Acquisition | +34,722 | – | 142,764 |
| 31 Oct 2026 | Mitchell Chan | Chief Financial Officer | Other Acquisition | +24,305 | – | 127,489 |
| 31 Oct 2026 | Craig Malzahn | Executive VP of Product Development & CTO | Other Acquisition | +27,777 | – | 109,737 |
| 31 Aug 2026 | Mitchell Chan | Chief Financial Officer | Sale to Issuer | -4,902 | $9.32 | 19,632 |
| 31 Aug 2026 | Craig Malzahn | Executive VP of Product Development & CTO | Sale to Issuer | -234 | $9.32 | 81,960 |
| 26 Aug 2026 | Gregory Ciongoli | Independent Director | Open Market Acquisition | +102,603 | $9.36 | 102,603 |
| 24 Aug 2026 | Gregory Ciongoli | Independent Director | Other Acquisition | +15,432 | – | 15,432 |
| 24 Aug 2026 | Gregory Ciongoli | Independent Director | Other Derivative Acquisition | +69,609 | $8.91 | 69,609 |
| 31 Jul 2026 | Stephen Pakola | Chief Medical Officer | Sale to Issuer | -7,468 | $9.69 | 52,802 |
| 31 Jul 2026 | Patrick Christmas | Executive VP and Chief Strategy & Legal Officer | Sale to Issuer | -4,699 | $9.69 | 97,927 |
| 1 Jul 2026 | Stephen Pakola | Chief Medical Officer | Derivative Exercise and Sale | -2,161 | $13.64 | 45,673 |
| 30 Jun 2026 | Curran Simpson | Chief Executive Officer | Sale to Issuer | -6,818 | $13.09 | 54,559 |
| 30 Jun 2026 | Stephen Pakola | Chief Medical Officer | Derivative Exercise and Sale | -36,725 | $12.86 | 45,673 |
| 29 Jun 2026 | Curran Simpson | Chief Executive Officer | Other Acquisition | +2,404 | $10.18 | 54,559 |
| 28 Jun 2026 | Stephen Pakola | Chief Medical Officer | Automatic Disposition | -19,608 | $11.04 | 45,673 |
| 28 May 2026 | David Stump | Independent Director | Other Acquisition | +9,807 | – | 9,807 |
| 28 May 2026 | David Stump | Independent Director | Other Derivative Acquisition | +46,600 | $7.01 | 46,600 |
| 28 May 2026 | George Migausky | Independent Chairperson | Other Acquisition | +9,807 | – | 9,807 |
| 28 May 2026 | George Migausky | Independent Chairperson | Other Derivative Acquisition | +46,600 | $7.01 | 46,600 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 10,179,714 | 15.4% | 8.3 |
| 15 Oct 2026 | 10,043,670 | 15.2% | 6.8 |
| 30 Sep 2026 | 9,608,992 | 14.6% | 6.0 |
| 15 Sep 2026 | 7,927,603 | 12.0% | 7.7 |
| 31 Aug 2026 | 7,497,221 | 11.4% | 4.9 |
| 14 Aug 2026 | 8,197,515 | 12.4% | 7.8 |
No comments yet — be the first to weigh in on RGNX.
Sign in to join the discussion.